Sign inGet started

STEIN EVAN A.

Insider CIK 1620461 · CBAY Director · XENE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CBAY CymaBay Therapeutics, Inc. A Award deriv2019-01-292019-01-3127,705— $027,705SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2018-01-242018-01-2616,000— $016,000SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2017-09-222017-09-267,500— $07,500SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2017-06-282017-06-3015,000— $015,000SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2017-01-192017-01-2312,000— $012,000SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2016-04-262016-04-2818,000— $018,000SEC↗
XENE Xenon Pharmaceuticals Inc. J Other2015-04-302015-05-04909,619— $0910,586SEC↗
XENE Xenon Pharmaceuticals Inc. J Other2015-04-302015-05-044,172— $04,172SEC↗
XENE Xenon Pharmaceuticals Inc. J Other2015-04-302015-05-041,038,964— $00SEC↗
XENE Xenon Pharmaceuticals Inc. C Conversion deriv2014-11-092014-11-121,038,964— $00SEC↗
XENE Xenon Pharmaceuticals Inc. C Conversion deriv2014-11-092014-11-12967— $00SEC↗
XENE Xenon Pharmaceuticals Inc. C Conversion2014-11-092014-11-121,038,964— $01,038,964SEC↗
XENE Xenon Pharmaceuticals Inc. C Conversion2014-11-092014-11-12967— $0967SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2014-11-042014-11-065,144— $05,144SEC↗